MarketWatch: Market response to COVID uptick and vaccine euphoria

Progress toward a vaccine for COVID-19 is undeniably good news, but U.S. stocks could falter if politicians can’t come up with a post-election deal on another round of aid spending to shore up a bruised economy, some investors fear.